Compare PLNT & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLNT | BAX |
|---|---|---|
| Founded | 1992 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 10.2B |
| IPO Year | 2015 | 1994 |
| Metric | PLNT | BAX |
|---|---|---|
| Price | $74.96 | $17.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 9 |
| Target Price | ★ $116.67 | $22.13 |
| AVG Volume (30 Days) | 2.0M | ★ 8.3M |
| Earning Date | 05-25-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,324,144,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $19.55 | $1.90 |
| Revenue Next Year | $11.83 | $2.09 |
| P/E Ratio | $38.47 | ★ N/A |
| Revenue Growth | ★ 12.06 | 5.72 |
| 52 Week Low | $73.32 | $17.07 |
| 52 Week High | $114.47 | $34.90 |
| Indicator | PLNT | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 30.93 | 33.46 |
| Support Level | N/A | N/A |
| Resistance Level | $113.11 | $19.31 |
| Average True Range (ATR) | 2.99 | 0.79 |
| MACD | -0.39 | -0.26 |
| Stochastic Oscillator | 16.30 | 6.60 |
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.